Close

GTX (GTXI) Reports Two POWER Trials Failed to Meet co-Primary Endpoints

Go back to GTX (GTXI) Reports Two POWER Trials Failed to Meet co-Primary Endpoints

Stifel Nicolaus Downgrades GTX Inc. (GTXI) to Hold

August 20, 2013 7:10 AM EDT

Stifel Nicolaus downgraded GTX Inc. (NASDAQ: GTXI) from Buy to Hold.

For an analyst ratings summary and ratings history on GTX Inc. click here. For more ratings news on GTX Inc. click here.

Shares of GTX Inc. closed at $1.43 yesterday, with a 52 week range of $1.31-$7.24.... More

Jefferies Downgrades GTX Inc. (GTXI) to Hold

August 19, 2013 1:28 PM EDT

Jefferies downgraded GTX Inc. (NASDAQ: GTXI) from Buy to Hold with a price target of $1.50.

For an analyst ratings summary and ratings history on GTX Inc. click here. For more ratings news on GTX Inc. click here.

Shares of GTX Inc. closed at $4.15 yesterday, with a 52 week range of $3.39-$7.24.... More

Wedbush Downgrades GTX Inc. (GTXI) to Neutral

August 19, 2013 1:00 PM EDT

Wedbush downgraded GTX Inc. (NASDAQ: GTXI) from Outperform to Neutral with a price target of $2.00 (from $9.00). This morning GTX, Inc. (Nasdaq: GTXI) announced results of its two Phase 3 enobosarm clinical trials, the POWER trials, in patients with non-small cell lung... More

GTX, Inc. (GTXI) trading halted with news pending

August 19, 2013 7:56 AM EDT

GTX, Inc. (NASDAQ: GTXI) trading halted with news pending.... More